CASE 3 APPLICATION OF COST-EFFECTIVENESS ANALYSIS TO EVALUATE THE PROPOSED FORMULARY STATUS OF A NOVEL ANTIDIABETIC DRUG IN A U.S. COMMERCIAL HEALTH PLAN

May 1, 2007, 00:00
10.1016/S1098-3015(10)69137-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)69137-1/fulltext
Title : CASE 3 APPLICATION OF COST-EFFECTIVENESS ANALYSIS TO EVALUATE THE PROPOSED FORMULARY STATUS OF A NOVEL ANTIDIABETIC DRUG IN A U.S. COMMERCIAL HEALTH PLAN
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)69137-1&doi=10.1016/S1098-3015(10)69137-1
First page :
Section Title :
Open access? : No
Section Order : 337
Categories :
Tags :
Regions :
ViH Article Tags :